Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuanling Yinhuang Formula
- Development stage
- Phase 4
- Lead developer
- Beijing Ditan Hospital
- Administration
- Oral
01
Overview
Xuanling Yinhuang Formula is a Traditional Chinese Medicine (TCM) herbal decoction developed by Beijing Ditan Hospital, Capital Medical University, for the treatment of central nervous system infections. It is primarily used as an adjunctive therapy for adult patients with viral encephalitis and viral meningitis, particularly those presenting with specific TCM syndromes such as phlegm-heat or damp-heat affecting the brain. In clinical trials, it is often evaluated in combination with Angong Niuhuang Bolus alongside standard Western antiviral and supportive treatments. The formula aims to clear heat, resolve phlegm, and detoxify the system to reduce neurological symptoms and improve recovery outcomes.
- Other names
- Xuanling Yinhuang Fang
Beyond the preview
Go deeper on Xuanling Yinhuang Formula.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xuanling Yinhuang Formula.